BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16150650)

  • 1. Hyperactive transposase mutants of the Sleeping Beauty transposon.
    Baus J; Liu L; Heggestad AD; Sanz S; Fletcher BS
    Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
    Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
    Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
    Score PR; Belur LR; Frandsen JL; Geurts JL; Yamaguchi T; Somia NV; Hackett PB; Largaespada DA; McIvor RS
    Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
    Izsvák Z; Ivics Z; Plasterk RH
    J Mol Biol; 2000 Sep; 302(1):93-102. PubMed ID: 10964563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-directed gene therapy using the sleeping beauty transposon system.
    Belur LR; McIvor RS; Wilber A
    Methods Mol Biol; 2008; 434():267-76. PubMed ID: 18470650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
    Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
    Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
    Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
    Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.
    Yant SR; Meuse L; Chiu W; Ivics Z; Izsvak Z; Kay MA
    Nat Genet; 2000 May; 25(1):35-41. PubMed ID: 10802653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.
    Izsvák Z; Chuah MK; Vandendriessche T; Ivics Z
    Methods; 2009 Nov; 49(3):287-97. PubMed ID: 19615447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase.
    Ehrhardt A; Xu H; Huang Z; Engler JA; Kay MA
    Mol Ther; 2005 May; 11(5):695-706. PubMed ID: 15851008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sleeping Beauty transposon toolbox.
    Ammar I; Izsvák Z; Ivics Z
    Methods Mol Biol; 2012; 859():229-40. PubMed ID: 22367875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon.
    Hollis RP; Nightingale SJ; Wang X; Pepper KA; Yu XJ; Barsky L; Crooks GM; Kohn DB
    Exp Hematol; 2006 Oct; 34(10):1333-43. PubMed ID: 16982326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
    Yant SR; Ehrhardt A; Mikkelsen JG; Meuse L; Pham T; Kay MA
    Nat Biotechnol; 2002 Oct; 20(10):999-1005. PubMed ID: 12244327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system.
    Belur LR; Podetz-Pedersen K; Frandsen J; McIvor RS
    Nat Protoc; 2007; 2(12):3146-52. PubMed ID: 18079714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of hyperactive sleeping beauty transposon vectors by mutational analysis.
    Zayed H; Izsvák Z; Walisko O; Ivics Z
    Mol Ther; 2004 Feb; 9(2):292-304. PubMed ID: 14759813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transposon-independent increase of transcription by the Sleeping Beauty transposase.
    Masuda K; Yamamoto S; Endoh M; Kaneda Y
    Biochem Biophys Res Commun; 2004 May; 317(3):796-800. PubMed ID: 15081410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awakening gene therapy with Sleeping Beauty transposons.
    Essner JJ; McIvor RS; Hackett PB
    Curr Opin Pharmacol; 2005 Oct; 5(5):513-9. PubMed ID: 16084771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer into genomes of human cells by the sleeping beauty transposon system.
    Geurts AM; Yang Y; Clark KJ; Liu G; Cui Z; Dupuy AJ; Bell JB; Largaespada DA; Hackett PB
    Mol Ther; 2003 Jul; 8(1):108-17. PubMed ID: 12842434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ancient mariner sails again: transposition of the human Hsmar1 element by a reconstructed transposase and activities of the SETMAR protein on transposon ends.
    Miskey C; Papp B; Mátés L; Sinzelle L; Keller H; Izsvák Z; Ivics Z
    Mol Cell Biol; 2007 Jun; 27(12):4589-600. PubMed ID: 17403897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a nonviral vector for site-selective, efficient integration into the human genome.
    Kaminski JM; Huber MR; Summers JB; Ward MB
    FASEB J; 2002 Aug; 16(10):1242-7. PubMed ID: 12153992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.